Aurobindo Pharma posts lower profitability in Q4 FY 11-12
Aurobindo Pharma has reported consolidated net sales of Rs 4567.6 crore in FY 11-12 as against Rs 4,125.9 crore in FY 10-11…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Swati Piramal elected member of Harvard Board of Overseers
Dr Swati Piramal, Director, Piramal Healthcare has been elected member of the Harvard Board of Overseers. Piramal is now one of…
Nestor Pharma plans second manufacturing facility in Nigeria
The company is also investing in its fourth domestic unit in Rajasthan Usha SharmaMumbai The Rs 300-crore Delhi-based…
Identifying India’s ‘magic beans’
This year’s US-India BioPharma & Healthcare Summit identified areas where India can create a niche for itself, but called for…
DIA’s conference talks on strategies to achieve global regulatory compliance
In line with its mission to find solutions to issues and challenges across the global drug development industry, DIA recently…
OPPI organises seminar on cold chain management in pharma industry
SACHIN JAGDALE — Mumbai Organisation of Pharmaceutical Produ-cers of India (OPPI) had recently organised a seminar on…
IHP, PFCD concludes expert panel discussion on NCDs
India Health Progress (IHP) and Partnership to Fight Chronic Disease (PFCD) had recently hosted a panel discussion in Chennai on…
Agreeing to disagree
At the recently concluded World Health Assembly in Geneva, one of the hotly debated topics was the adoption of a global Convention…
‘Consumer education is of utmost importance in this category’
With its recent launch of B3 (B Cube), an advanced sports nutrition supplement, the Yash Birla Group has become the first Indian…
Waters Corporation starts online services
Waters Corporation is marking its 25th anniversary of the start of business operations in India, with the initiation of online…